Genetic Study Shows Risk of Preeclampsia is Related to Blood Pressure and BMI

Priscilla Lynch 

December 03, 2020

The genetic risk of pre-eclampsia is related to blood pressure and body mass index (BMI), suggests a large-scale meta-analysis of maternal pre-eclampsia coupled with the findings of an international pregnancy genetics study coordinated by UK researchers.

In the InterPregGen study, researchers studied how maternal genetic variation influences the risk of pre-eclampsia. The team studied the genome-wide association scans of 9515 pre-eclamptic women and 157,719 control individuals.

The results, published in  Nature Communications,  pinpointed DNA variants in the ZNF831 and FTO genes as risk factors for pre-eclampsia. These genes have previously been associated with blood pressure, and the FTO variant also with BMI. Further analysis revealed other blood pressure-related variants in the MECOM, FGF5 and SH2B3 genes also associating with pre-eclampsia. These variants increase the risk of pre-eclampsia by 10-15 per cent.

The study also shows that overall genetic predisposition to hypertension is a major risk factor for pre-eclampsia and thus a large number of variants each with a small effect may also contribute to the risk. These current results complement the earlier findings of the same researchers, who showed that a variant near FLT1 gene in the foetal genome affects mothers’ risk of developing pre-eclampsia.

The genes identified so far correlate with other current knowledge of pre-eclampsia as hypertension and obesity are known maternal risk factors.

While this study shows that these associations are partly explained by inherited predispositions, whether the remaining unidentified pre-eclampsia factors act through the maternal or foetal genome, or both, remains to be seen.

Study co-author Prof Fiona Broughton Pipkin, University of Nottingham, said: “The new insights from this study could form the basis for more effective prevention and treatment of pre-eclampsia in the future, and improve the outcome of pregnancy for mother and child. They could also encourage GPs to follow-up more closely women who have had pre-eclampsia.”

Steinthorsdottir V, McGinnis R, Williams NO, Stefansdottir L, Thorleifsson G, Shooter S, Fadista J, Sigurdsson JK, Auro KM, Berezina G, Borges MC, Bumpstead S, Bybjerg-Grauholm J, Colgiu I, Dolby VA, Dudbridge F, Engel SM, Franklin CS, Frigge ML, Frisbaek Y, Geirsson RT, Geller F, Gretarsdottir S, Gudbjartsson DF, Harmon Q, Hougaard DM, Hegay T, Helgadottir A, Hjartardottir S, Jääskeläinen T, Johannsdottir H, Jonsdottir I, Juliusdottir T, Kalsheker N, Kasimov A, Kemp JP, Kivinen K, Klungsøyr K, Lee WK, Melbye M, Miedzybrodska Z, Moffett A, Najmutdinova D, Nishanova F, Olafsdottir T, Perola M, Pipkin FB, Poston L, Prescott G, Saevarsdottir S, Salimbayeva D, Scaife PJ, Skotte L, Staines-Urias E, Stefansson OA, Sørensen KM, Thomsen LCV, Tragante V, Trogstad L, Simpson NAB, Aripova T, Casas JP, Dominiczak AF, Walker JJ, Thorsteinsdottir U, Iversen AC, Feenstra B, Lawlor DA, Boyd HA, Magnus P, Laivuori H, Zakhidova N, Svyatova G, Stefansson K, Morgan L. Genetic predisposition to hypertension is associated with preeclampsia in European and Central Asian women. Nat Commun. 2020;11(1):5976. doi: 10.1038/s41467-020-19733-6. PMID: 33239696 View full text

This article originally appeared on Univadis, part of the Medscape Professional Network.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: